Your session is about to expire
← Back to Search
Neurostimulation Device
Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain
N/A
Waitlist Available
Research Sponsored by St. Louis University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a small, non-invasive device called IB-Stim that sends mild electrical signals to reduce abdominal pain in children with Cystic Fibrosis. The device works by stimulating a nerve that helps control pain, aiming to improve their quality of life.
Eligible Conditions
- Cystic Fibrosis
- Chronic Pain
- Irritable Bowel Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
CFQ-R and PedsQL Gastrointestinal Scale Score in Response to IB-Stim Treatment- Baseline and Week 8 Reported
IBS Severity Scoring System-Change Between Baseline and Week 8 is Reported.
Reduction in Stool Calprotectin Inflammatory Markers in Response to IB-Stim-change Between Two Time Point is Reported.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patient open label intervention armExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
St. Louis UniversityLead Sponsor
194 Previous Clinical Trials
41,022 Total Patients Enrolled
1 Trials studying Cystic Fibrosis
3 Patients Enrolled for Cystic Fibrosis
Washington University School of MedicineOTHER
1,997 Previous Clinical Trials
2,298,760 Total Patients Enrolled
7 Trials studying Cystic Fibrosis
851 Patients Enrolled for Cystic Fibrosis